nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—UGT1A1—Naltrexone—alcohol dependence	0.224	0.479	CbGbCtD
Nilotinib—CYP2B6—Citalopram—alcohol dependence	0.0573	0.123	CbGbCtD
Nilotinib—ABCB1—Naltrexone—alcohol dependence	0.0443	0.0949	CbGbCtD
Nilotinib—CYP2C9—Disulfiram—alcohol dependence	0.0425	0.0909	CbGbCtD
Nilotinib—ABCB1—Citalopram—alcohol dependence	0.0294	0.0629	CbGbCtD
Nilotinib—CYP2D6—Citalopram—alcohol dependence	0.0277	0.0593	CbGbCtD
Nilotinib—CYP3A4—Disulfiram—alcohol dependence	0.0247	0.0529	CbGbCtD
Nilotinib—CYP3A4—Citalopram—alcohol dependence	0.0176	0.0377	CbGbCtD
Nilotinib—HCK—central nervous system—alcohol dependence	0.000416	0.00258	CbGeAlD
Nilotinib—EPHA2—blood—alcohol dependence	0.000415	0.00258	CbGeAlD
Nilotinib—CA3—endocrine gland—alcohol dependence	0.000414	0.00257	CbGeAlD
Nilotinib—ABL2—liver—alcohol dependence	0.000414	0.00257	CbGeAlD
Nilotinib—CSF1R—cardiovascular system—alcohol dependence	0.000408	0.00253	CbGeAlD
Nilotinib—TEK—blood—alcohol dependence	0.000405	0.00251	CbGeAlD
Nilotinib—ABL2—cerebellum—alcohol dependence	0.000404	0.00251	CbGeAlD
Nilotinib—LYN—brain—alcohol dependence	0.000402	0.0025	CbGeAlD
Nilotinib—CA1—forebrain—alcohol dependence	0.000401	0.00249	CbGeAlD
Nilotinib—EPHA4—testis—alcohol dependence	0.0004	0.00248	CbGeAlD
Nilotinib—TEK—midbrain—alcohol dependence	0.0004	0.00248	CbGeAlD
Nilotinib—CA7—cerebellum—alcohol dependence	0.000398	0.00247	CbGeAlD
Nilotinib—CA9—endocrine gland—alcohol dependence	0.000397	0.00246	CbGeAlD
Nilotinib—PDGFRB—adrenal cortex—alcohol dependence	0.000397	0.00246	CbGeAlD
Nilotinib—MAP4K1—brain—alcohol dependence	0.000396	0.00246	CbGeAlD
Nilotinib—ABL1—brainstem—alcohol dependence	0.000395	0.00246	CbGeAlD
Nilotinib—CA3—testis—alcohol dependence	0.000395	0.00245	CbGeAlD
Nilotinib—EPHA4—nervous system—alcohol dependence	0.000393	0.00244	CbGeAlD
Nilotinib—CA3—nervous system—alcohol dependence	0.000388	0.00241	CbGeAlD
Nilotinib—MAPK14—endocrine gland—alcohol dependence	0.000387	0.0024	CbGeAlD
Nilotinib—EPHB6—blood—alcohol dependence	0.000387	0.0024	CbGeAlD
Nilotinib—FGR—endocrine gland—alcohol dependence	0.000385	0.00239	CbGeAlD
Nilotinib—PDGFRA—digestive system—alcohol dependence	0.000385	0.00239	CbGeAlD
Nilotinib—EPHB6—midbrain—alcohol dependence	0.000382	0.00237	CbGeAlD
Nilotinib—CA9—testis—alcohol dependence	0.000378	0.00235	CbGeAlD
Nilotinib—EPHA4—central nervous system—alcohol dependence	0.000378	0.00235	CbGeAlD
Nilotinib—TIE1—brain—alcohol dependence	0.000378	0.00235	CbGeAlD
Nilotinib—CA3—liver—alcohol dependence	0.000374	0.00232	CbGeAlD
Nilotinib—CA3—central nervous system—alcohol dependence	0.000373	0.00232	CbGeAlD
Nilotinib—KIT—cardiovascular system—alcohol dependence	0.000371	0.0023	CbGeAlD
Nilotinib—CSF1R—gonad—alcohol dependence	0.00037	0.0023	CbGeAlD
Nilotinib—EPHA4—cerebellum—alcohol dependence	0.00037	0.0023	CbGeAlD
Nilotinib—MAPK14—testis—alcohol dependence	0.000369	0.00229	CbGeAlD
Nilotinib—LCK—testis—alcohol dependence	0.000367	0.00228	CbGeAlD
Nilotinib—FGR—testis—alcohol dependence	0.000367	0.00228	CbGeAlD
Nilotinib—UGT1A1—digestive system—alcohol dependence	0.000367	0.00228	CbGeAlD
Nilotinib—EPHB4—endocrine gland—alcohol dependence	0.000367	0.00228	CbGeAlD
Nilotinib—PDGFRA—blood—alcohol dependence	0.000367	0.00228	CbGeAlD
Nilotinib—BRAF—brain—alcohol dependence	0.000362	0.00225	CbGeAlD
Nilotinib—MAPK14—nervous system—alcohol dependence	0.000362	0.00225	CbGeAlD
Nilotinib—PDGFRB—cardiovascular system—alcohol dependence	0.000362	0.00225	CbGeAlD
Nilotinib—Alopecia—Acamprosate—alcohol dependence	0.000361	0.00147	CcSEcCtD
Nilotinib—FGR—nervous system—alcohol dependence	0.000361	0.00224	CbGeAlD
Nilotinib—Tinnitus—Naltrexone—alcohol dependence	0.00036	0.00146	CcSEcCtD
Nilotinib—KIT—pancreas—alcohol dependence	0.00036	0.00224	CbGeAlD
Nilotinib—EPHA2—endocrine gland—alcohol dependence	0.00036	0.00223	CbGeAlD
Nilotinib—EPHB3—brain—alcohol dependence	0.000359	0.00223	CbGeAlD
Nilotinib—Cardiac disorder—Naltrexone—alcohol dependence	0.000359	0.00146	CcSEcCtD
Nilotinib—Mental disorder—Acamprosate—alcohol dependence	0.000358	0.00145	CcSEcCtD
Nilotinib—Malnutrition—Acamprosate—alcohol dependence	0.000356	0.00144	CcSEcCtD
Nilotinib—Hyponatraemia—Citalopram—alcohol dependence	0.000355	0.00144	CcSEcCtD
Nilotinib—CA12—digestive system—alcohol dependence	0.000355	0.00221	CbGeAlD
Nilotinib—Pain in extremity—Citalopram—alcohol dependence	0.000354	0.00144	CcSEcCtD
Nilotinib—Diplopia—Citalopram—alcohol dependence	0.000354	0.00144	CcSEcCtD
Nilotinib—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000354	0.00144	CcSEcCtD
Nilotinib—ABL1—adrenal cortex—alcohol dependence	0.000354	0.0022	CbGeAlD
Nilotinib—PDGFRB—pancreas—alcohol dependence	0.000352	0.00218	CbGeAlD
Nilotinib—TEK—endocrine gland—alcohol dependence	0.000351	0.00218	CbGeAlD
Nilotinib—Angiopathy—Naltrexone—alcohol dependence	0.000351	0.00142	CcSEcCtD
Nilotinib—Flatulence—Acamprosate—alcohol dependence	0.00035	0.00142	CcSEcCtD
Nilotinib—EPHB4—testis—alcohol dependence	0.00035	0.00217	CbGeAlD
Nilotinib—UGT1A1—blood—alcohol dependence	0.00035	0.00217	CbGeAlD
Nilotinib—CA9—cerebellum—alcohol dependence	0.000349	0.00217	CbGeAlD
Nilotinib—Immune system disorder—Naltrexone—alcohol dependence	0.000349	0.00142	CcSEcCtD
Nilotinib—MAPK14—liver—alcohol dependence	0.000349	0.00217	CbGeAlD
Nilotinib—MAPK14—central nervous system—alcohol dependence	0.000349	0.00216	CbGeAlD
Nilotinib—Migraine—Citalopram—alcohol dependence	0.000348	0.00142	CcSEcCtD
Nilotinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.000348	0.00141	CcSEcCtD
Nilotinib—Dysgeusia—Acamprosate—alcohol dependence	0.000348	0.00141	CcSEcCtD
Nilotinib—LCK—liver—alcohol dependence	0.000347	0.00216	CbGeAlD
Nilotinib—FGR—liver—alcohol dependence	0.000347	0.00216	CbGeAlD
Nilotinib—FGR—central nervous system—alcohol dependence	0.000347	0.00216	CbGeAlD
Nilotinib—Chills—Naltrexone—alcohol dependence	0.000347	0.00141	CcSEcCtD
Nilotinib—Back pain—Acamprosate—alcohol dependence	0.000344	0.0014	CcSEcCtD
Nilotinib—EPHA2—testis—alcohol dependence	0.000343	0.00213	CbGeAlD
Nilotinib—Muscle spasms—Acamprosate—alcohol dependence	0.000342	0.00139	CcSEcCtD
Nilotinib—Face oedema—Citalopram—alcohol dependence	0.000342	0.00139	CcSEcCtD
Nilotinib—Alopecia—Naltrexone—alcohol dependence	0.000341	0.00139	CcSEcCtD
Nilotinib—MAPK14—cerebellum—alcohol dependence	0.000341	0.00212	CbGeAlD
Nilotinib—CA14—liver—alcohol dependence	0.000339	0.00211	CbGeAlD
Nilotinib—CA1—cardiovascular system—alcohol dependence	0.000339	0.00211	CbGeAlD
Nilotinib—CSF1R—digestive system—alcohol dependence	0.000339	0.0021	CbGeAlD
Nilotinib—Mental disorder—Naltrexone—alcohol dependence	0.000339	0.00138	CcSEcCtD
Nilotinib—EPHA2—nervous system—alcohol dependence	0.000337	0.00209	CbGeAlD
Nilotinib—Malnutrition—Naltrexone—alcohol dependence	0.000336	0.00137	CcSEcCtD
Nilotinib—KIT—gonad—alcohol dependence	0.000336	0.00209	CbGeAlD
Nilotinib—TEK—testis—alcohol dependence	0.000335	0.00208	CbGeAlD
Nilotinib—Tremor—Acamprosate—alcohol dependence	0.000333	0.00135	CcSEcCtD
Nilotinib—Flatulence—Naltrexone—alcohol dependence	0.000331	0.00135	CcSEcCtD
Nilotinib—CA14—cerebellum—alcohol dependence	0.000331	0.00206	CbGeAlD
Nilotinib—MAP2K5—blood—alcohol dependence	0.000331	0.00205	CbGeAlD
Nilotinib—EPHB4—liver—alcohol dependence	0.000331	0.00205	CbGeAlD
Nilotinib—HCK—brain—alcohol dependence	0.00033	0.00205	CbGeAlD
Nilotinib—Ill-defined disorder—Acamprosate—alcohol dependence	0.00033	0.00134	CcSEcCtD
Nilotinib—CA1—pancreas—alcohol dependence	0.000329	0.00205	CbGeAlD
Nilotinib—Dysgeusia—Naltrexone—alcohol dependence	0.000329	0.00134	CcSEcCtD
Nilotinib—Dehydration—Citalopram—alcohol dependence	0.000329	0.00134	CcSEcCtD
Nilotinib—Anaemia—Acamprosate—alcohol dependence	0.000329	0.00134	CcSEcCtD
Nilotinib—PDGFRB—gonad—alcohol dependence	0.000329	0.00204	CbGeAlD
Nilotinib—TEK—nervous system—alcohol dependence	0.000328	0.00204	CbGeAlD
Nilotinib—ABL2—brain—alcohol dependence	0.000328	0.00204	CbGeAlD
Nilotinib—MAP2K5—midbrain—alcohol dependence	0.000327	0.00203	CbGeAlD
Nilotinib—Back pain—Naltrexone—alcohol dependence	0.000325	0.00132	CcSEcCtD
Nilotinib—CA4—brainstem—alcohol dependence	0.000325	0.00202	CbGeAlD
Nilotinib—Dry skin—Citalopram—alcohol dependence	0.000324	0.00132	CcSEcCtD
Nilotinib—EPHA2—liver—alcohol dependence	0.000324	0.00201	CbGeAlD
Nilotinib—EPHA2—central nervous system—alcohol dependence	0.000324	0.00201	CbGeAlD
Nilotinib—Muscle spasms—Naltrexone—alcohol dependence	0.000323	0.00131	CcSEcCtD
Nilotinib—Abdominal pain upper—Citalopram—alcohol dependence	0.000323	0.00131	CcSEcCtD
Nilotinib—CA7—brain—alcohol dependence	0.000323	0.00201	CbGeAlD
Nilotinib—EPHB4—cerebellum—alcohol dependence	0.000323	0.00201	CbGeAlD
Nilotinib—CSF1R—blood—alcohol dependence	0.000323	0.002	CbGeAlD
Nilotinib—ABL1—cardiovascular system—alcohol dependence	0.000323	0.002	CbGeAlD
Nilotinib—Hypokalaemia—Citalopram—alcohol dependence	0.000322	0.00131	CcSEcCtD
Nilotinib—Malaise—Acamprosate—alcohol dependence	0.000321	0.0013	CcSEcCtD
Nilotinib—EPHB6—testis—alcohol dependence	0.00032	0.00199	CbGeAlD
Nilotinib—Breast disorder—Citalopram—alcohol dependence	0.00032	0.0013	CcSEcCtD
Nilotinib—Vertigo—Acamprosate—alcohol dependence	0.000319	0.0013	CcSEcCtD
Nilotinib—Syncope—Acamprosate—alcohol dependence	0.000319	0.0013	CcSEcCtD
Nilotinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000319	0.00129	CcSEcCtD
Nilotinib—CSF1R—midbrain—alcohol dependence	0.000319	0.00198	CbGeAlD
Nilotinib—Leukopenia—Acamprosate—alcohol dependence	0.000318	0.00129	CcSEcCtD
Nilotinib—PDGFRA—endocrine gland—alcohol dependence	0.000318	0.00197	CbGeAlD
Nilotinib—Vision blurred—Naltrexone—alcohol dependence	0.000317	0.00129	CcSEcCtD
Nilotinib—Nasopharyngitis—Citalopram—alcohol dependence	0.000317	0.00129	CcSEcCtD
Nilotinib—TEK—liver—alcohol dependence	0.000316	0.00197	CbGeAlD
Nilotinib—TEK—central nervous system—alcohol dependence	0.000316	0.00196	CbGeAlD
Nilotinib—Tremor—Naltrexone—alcohol dependence	0.000315	0.00128	CcSEcCtD
Nilotinib—Palpitations—Acamprosate—alcohol dependence	0.000314	0.00128	CcSEcCtD
Nilotinib—EPHB6—nervous system—alcohol dependence	0.000314	0.00195	CbGeAlD
Nilotinib—ABL1—pancreas—alcohol dependence	0.000314	0.00195	CbGeAlD
Nilotinib—CA4—forebrain—alcohol dependence	0.000313	0.00195	CbGeAlD
Nilotinib—Gastritis—Citalopram—alcohol dependence	0.000313	0.00127	CcSEcCtD
Nilotinib—Loss of consciousness—Acamprosate—alcohol dependence	0.000313	0.00127	CcSEcCtD
Nilotinib—Muscular weakness—Citalopram—alcohol dependence	0.000312	0.00127	CcSEcCtD
Nilotinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000312	0.00127	CcSEcCtD
Nilotinib—Ill-defined disorder—Naltrexone—alcohol dependence	0.000312	0.00127	CcSEcCtD
Nilotinib—Cough—Acamprosate—alcohol dependence	0.00031	0.00126	CcSEcCtD
Nilotinib—TEK—cerebellum—alcohol dependence	0.000309	0.00192	CbGeAlD
Nilotinib—Abdominal distension—Citalopram—alcohol dependence	0.000308	0.00125	CcSEcCtD
Nilotinib—KIT—digestive system—alcohol dependence	0.000308	0.00191	CbGeAlD
Nilotinib—Hypertension—Acamprosate—alcohol dependence	0.000307	0.00125	CcSEcCtD
Nilotinib—Influenza—Citalopram—alcohol dependence	0.000306	0.00124	CcSEcCtD
Nilotinib—Malaise—Naltrexone—alcohol dependence	0.000303	0.00123	CcSEcCtD
Nilotinib—UGT1A1—endocrine gland—alcohol dependence	0.000303	0.00188	CbGeAlD
Nilotinib—PDGFRA—testis—alcohol dependence	0.000303	0.00188	CbGeAlD
Nilotinib—Eosinophilia—Citalopram—alcohol dependence	0.000303	0.00123	CcSEcCtD
Nilotinib—Myalgia—Acamprosate—alcohol dependence	0.000303	0.00123	CcSEcCtD
Nilotinib—Arthralgia—Acamprosate—alcohol dependence	0.000303	0.00123	CcSEcCtD
Nilotinib—Chest pain—Acamprosate—alcohol dependence	0.000303	0.00123	CcSEcCtD
Nilotinib—EPHB6—central nervous system—alcohol dependence	0.000302	0.00188	CbGeAlD
Nilotinib—Syncope—Naltrexone—alcohol dependence	0.000302	0.00123	CcSEcCtD
Nilotinib—Anxiety—Acamprosate—alcohol dependence	0.000302	0.00123	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000301	0.00122	CcSEcCtD
Nilotinib—PDGFRB—digestive system—alcohol dependence	0.0003	0.00187	CbGeAlD
Nilotinib—EPHA4—brain—alcohol dependence	0.0003	0.00186	CbGeAlD
Nilotinib—Pancreatitis—Citalopram—alcohol dependence	0.0003	0.00122	CcSEcCtD
Nilotinib—Discomfort—Acamprosate—alcohol dependence	0.000299	0.00122	CcSEcCtD
Nilotinib—Angina pectoris—Citalopram—alcohol dependence	0.000298	0.00121	CcSEcCtD
Nilotinib—PDGFRA—nervous system—alcohol dependence	0.000298	0.00185	CbGeAlD
Nilotinib—Palpitations—Naltrexone—alcohol dependence	0.000297	0.00121	CcSEcCtD
Nilotinib—CA3—brain—alcohol dependence	0.000296	0.00184	CbGeAlD
Nilotinib—Dry mouth—Acamprosate—alcohol dependence	0.000296	0.0012	CcSEcCtD
Nilotinib—Loss of consciousness—Naltrexone—alcohol dependence	0.000296	0.0012	CcSEcCtD
Nilotinib—EPHB6—cerebellum—alcohol dependence	0.000295	0.00183	CbGeAlD
Nilotinib—Bronchitis—Citalopram—alcohol dependence	0.000294	0.0012	CcSEcCtD
Nilotinib—Cough—Naltrexone—alcohol dependence	0.000294	0.00119	CcSEcCtD
Nilotinib—CA12—endocrine gland—alcohol dependence	0.000293	0.00182	CbGeAlD
Nilotinib—Abdominal discomfort—Citalopram—alcohol dependence	0.000293	0.00119	CcSEcCtD
Nilotinib—KIT—blood—alcohol dependence	0.000293	0.00182	CbGeAlD
Nilotinib—ABL1—gonad—alcohol dependence	0.000293	0.00182	CbGeAlD
Nilotinib—Confusional state—Acamprosate—alcohol dependence	0.000293	0.00119	CcSEcCtD
Nilotinib—Pancytopenia—Citalopram—alcohol dependence	0.000291	0.00118	CcSEcCtD
Nilotinib—Hypertension—Naltrexone—alcohol dependence	0.00029	0.00118	CcSEcCtD
Nilotinib—KIT—midbrain—alcohol dependence	0.000289	0.0018	CbGeAlD
Nilotinib—Infection—Acamprosate—alcohol dependence	0.000288	0.00117	CcSEcCtD
Nilotinib—MAP2K5—endocrine gland—alcohol dependence	0.000287	0.00178	CbGeAlD
Nilotinib—PDGFRA—liver—alcohol dependence	0.000287	0.00178	CbGeAlD
Nilotinib—PDGFRA—central nervous system—alcohol dependence	0.000287	0.00178	CbGeAlD
Nilotinib—Myalgia—Naltrexone—alcohol dependence	0.000286	0.00116	CcSEcCtD
Nilotinib—Arthralgia—Naltrexone—alcohol dependence	0.000286	0.00116	CcSEcCtD
Nilotinib—Chest pain—Naltrexone—alcohol dependence	0.000286	0.00116	CcSEcCtD
Nilotinib—PDGFRB—blood—alcohol dependence	0.000286	0.00178	CbGeAlD
Nilotinib—Dysuria—Citalopram—alcohol dependence	0.000286	0.00116	CcSEcCtD
Nilotinib—Shock—Acamprosate—alcohol dependence	0.000286	0.00116	CcSEcCtD
Nilotinib—Anxiety—Naltrexone—alcohol dependence	0.000285	0.00116	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000284	0.00116	CcSEcCtD
Nilotinib—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000284	0.00116	CcSEcCtD
Nilotinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000284	0.00115	CcSEcCtD
Nilotinib—Tachycardia—Acamprosate—alcohol dependence	0.000283	0.00115	CcSEcCtD
Nilotinib—Discomfort—Naltrexone—alcohol dependence	0.000283	0.00115	CcSEcCtD
Nilotinib—PDGFRB—midbrain—alcohol dependence	0.000283	0.00176	CbGeAlD
Nilotinib—Pollakiuria—Citalopram—alcohol dependence	0.000283	0.00115	CcSEcCtD
Nilotinib—Skin disorder—Acamprosate—alcohol dependence	0.000282	0.00115	CcSEcCtD
Nilotinib—Erectile dysfunction—Citalopram—alcohol dependence	0.000282	0.00114	CcSEcCtD
Nilotinib—CA1—digestive system—alcohol dependence	0.000281	0.00175	CbGeAlD
Nilotinib—Hyperhidrosis—Acamprosate—alcohol dependence	0.000281	0.00114	CcSEcCtD
Nilotinib—Dry mouth—Naltrexone—alcohol dependence	0.00028	0.00114	CcSEcCtD
Nilotinib—PDGFRA—cerebellum—alcohol dependence	0.00028	0.00174	CbGeAlD
Nilotinib—CSF1R—endocrine gland—alcohol dependence	0.00028	0.00174	CbGeAlD
Nilotinib—Photosensitivity reaction—Citalopram—alcohol dependence	0.000279	0.00113	CcSEcCtD
Nilotinib—Weight increased—Citalopram—alcohol dependence	0.000278	0.00113	CcSEcCtD
Nilotinib—Confusional state—Naltrexone—alcohol dependence	0.000277	0.00112	CcSEcCtD
Nilotinib—Weight decreased—Citalopram—alcohol dependence	0.000277	0.00112	CcSEcCtD
Nilotinib—MAPK14—brain—alcohol dependence	0.000277	0.00172	CbGeAlD
Nilotinib—Anorexia—Acamprosate—alcohol dependence	0.000277	0.00112	CcSEcCtD
Nilotinib—Hyperglycaemia—Citalopram—alcohol dependence	0.000276	0.00112	CcSEcCtD
Nilotinib—FGR—brain—alcohol dependence	0.000276	0.00171	CbGeAlD
Nilotinib—CA12—nervous system—alcohol dependence	0.000275	0.00171	CbGeAlD
Nilotinib—Oedema—Naltrexone—alcohol dependence	0.000275	0.00112	CcSEcCtD
Nilotinib—Pneumonia—Citalopram—alcohol dependence	0.000274	0.00111	CcSEcCtD
Nilotinib—MAP2K5—testis—alcohol dependence	0.000274	0.0017	CbGeAlD
Nilotinib—UGT1A1—liver—alcohol dependence	0.000273	0.0017	CbGeAlD
Nilotinib—Infection—Naltrexone—alcohol dependence	0.000273	0.00111	CcSEcCtD
Nilotinib—Infestation—Citalopram—alcohol dependence	0.000273	0.00111	CcSEcCtD
Nilotinib—Infestation NOS—Citalopram—alcohol dependence	0.000273	0.00111	CcSEcCtD
Nilotinib—Hypotension—Acamprosate—alcohol dependence	0.000271	0.0011	CcSEcCtD
Nilotinib—Shock—Naltrexone—alcohol dependence	0.00027	0.0011	CcSEcCtD
Nilotinib—Nervous system disorder—Naltrexone—alcohol dependence	0.000269	0.00109	CcSEcCtD
Nilotinib—CA14—brain—alcohol dependence	0.000269	0.00167	CbGeAlD
Nilotinib—CA2—brainstem—alcohol dependence	0.000269	0.00167	CbGeAlD
Nilotinib—Acute coronary syndrome—Citalopram—alcohol dependence	0.000269	0.00109	CcSEcCtD
Nilotinib—MAP2K5—nervous system—alcohol dependence	0.000268	0.00167	CbGeAlD
Nilotinib—CA1—blood—alcohol dependence	0.000268	0.00166	CbGeAlD
Nilotinib—Tachycardia—Naltrexone—alcohol dependence	0.000268	0.00109	CcSEcCtD
Nilotinib—ABL1—digestive system—alcohol dependence	0.000268	0.00166	CbGeAlD
Nilotinib—Neuropathy peripheral—Citalopram—alcohol dependence	0.000267	0.00109	CcSEcCtD
Nilotinib—Myocardial infarction—Citalopram—alcohol dependence	0.000267	0.00109	CcSEcCtD
Nilotinib—CSF1R—testis—alcohol dependence	0.000267	0.00166	CbGeAlD
Nilotinib—Skin disorder—Naltrexone—alcohol dependence	0.000267	0.00108	CcSEcCtD
Nilotinib—Jaundice—Citalopram—alcohol dependence	0.000266	0.00108	CcSEcCtD
Nilotinib—Stomatitis—Citalopram—alcohol dependence	0.000266	0.00108	CcSEcCtD
Nilotinib—Hyperhidrosis—Naltrexone—alcohol dependence	0.000265	0.00108	CcSEcCtD
Nilotinib—Urinary tract infection—Citalopram—alcohol dependence	0.000265	0.00108	CcSEcCtD
Nilotinib—Conjunctivitis—Citalopram—alcohol dependence	0.000265	0.00108	CcSEcCtD
Nilotinib—CA4—cardiovascular system—alcohol dependence	0.000265	0.00165	CbGeAlD
Nilotinib—CA12—central nervous system—alcohol dependence	0.000264	0.00164	CbGeAlD
Nilotinib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000264	0.00107	CcSEcCtD
Nilotinib—Insomnia—Acamprosate—alcohol dependence	0.000262	0.00107	CcSEcCtD
Nilotinib—EPHB4—brain—alcohol dependence	0.000262	0.00163	CbGeAlD
Nilotinib—CSF1R—nervous system—alcohol dependence	0.000262	0.00163	CbGeAlD
Nilotinib—Anorexia—Naltrexone—alcohol dependence	0.000262	0.00106	CcSEcCtD
Nilotinib—Paraesthesia—Acamprosate—alcohol dependence	0.000261	0.00106	CcSEcCtD
Nilotinib—Haematuria—Citalopram—alcohol dependence	0.00026	0.00106	CcSEcCtD
Nilotinib—CA2—forebrain—alcohol dependence	0.00026	0.00161	CbGeAlD
Nilotinib—Dyspnoea—Acamprosate—alcohol dependence	0.000259	0.00105	CcSEcCtD
Nilotinib—MAP2K5—liver—alcohol dependence	0.000259	0.00161	CbGeAlD
Nilotinib—MAP2K5—central nervous system—alcohol dependence	0.000258	0.00161	CbGeAlD
Nilotinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000258	0.00105	CcSEcCtD
Nilotinib—EPHA2—brain—alcohol dependence	0.000257	0.0016	CbGeAlD
Nilotinib—Epistaxis—Citalopram—alcohol dependence	0.000257	0.00105	CcSEcCtD
Nilotinib—Dyspepsia—Acamprosate—alcohol dependence	0.000255	0.00104	CcSEcCtD
Nilotinib—ABL1—blood—alcohol dependence	0.000255	0.00158	CbGeAlD
Nilotinib—KIT—endocrine gland—alcohol dependence	0.000254	0.00158	CbGeAlD
Nilotinib—MAP2K5—cerebellum—alcohol dependence	0.000253	0.00157	CbGeAlD
Nilotinib—CSF1R—liver—alcohol dependence	0.000252	0.00157	CbGeAlD
Nilotinib—CSF1R—central nervous system—alcohol dependence	0.000252	0.00157	CbGeAlD
Nilotinib—Decreased appetite—Acamprosate—alcohol dependence	0.000252	0.00102	CcSEcCtD
Nilotinib—ABL1—midbrain—alcohol dependence	0.000252	0.00156	CbGeAlD
Nilotinib—TEK—brain—alcohol dependence	0.000251	0.00156	CbGeAlD
Nilotinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000251	0.00102	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00025	0.00102	CcSEcCtD
Nilotinib—Bradycardia—Citalopram—alcohol dependence	0.000249	0.00101	CcSEcCtD
Nilotinib—Insomnia—Naltrexone—alcohol dependence	0.000248	0.00101	CcSEcCtD
Nilotinib—PDGFRB—endocrine gland—alcohol dependence	0.000248	0.00154	CbGeAlD
Nilotinib—Pain—Acamprosate—alcohol dependence	0.000248	0.00101	CcSEcCtD
Nilotinib—Constipation—Acamprosate—alcohol dependence	0.000248	0.00101	CcSEcCtD
Nilotinib—CSF1R—cerebellum—alcohol dependence	0.000247	0.00153	CbGeAlD
Nilotinib—Paraesthesia—Naltrexone—alcohol dependence	0.000247	0.001	CcSEcCtD
Nilotinib—Haemoglobin—Citalopram—alcohol dependence	0.000246	0.001	CcSEcCtD
Nilotinib—Rhinitis—Citalopram—alcohol dependence	0.000245	0.000997	CcSEcCtD
Nilotinib—Haemorrhage—Citalopram—alcohol dependence	0.000245	0.000995	CcSEcCtD
Nilotinib—Hepatitis—Citalopram—alcohol dependence	0.000245	0.000995	CcSEcCtD
Nilotinib—Dyspnoea—Naltrexone—alcohol dependence	0.000245	0.000994	CcSEcCtD
Nilotinib—Hypoaesthesia—Citalopram—alcohol dependence	0.000244	0.00099	CcSEcCtD
Nilotinib—Pharyngitis—Citalopram—alcohol dependence	0.000243	0.000987	CcSEcCtD
Nilotinib—KIT—testis—alcohol dependence	0.000242	0.00151	CbGeAlD
Nilotinib—Urinary tract disorder—Citalopram—alcohol dependence	0.000242	0.000982	CcSEcCtD
Nilotinib—Oedema peripheral—Citalopram—alcohol dependence	0.000241	0.00098	CcSEcCtD
Nilotinib—CA2—adrenal cortex—alcohol dependence	0.000241	0.00149	CbGeAlD
Nilotinib—Connective tissue disorder—Citalopram—alcohol dependence	0.000241	0.000977	CcSEcCtD
Nilotinib—Urethral disorder—Citalopram—alcohol dependence	0.00024	0.000975	CcSEcCtD
Nilotinib—EPHB6—brain—alcohol dependence	0.00024	0.00149	CbGeAlD
Nilotinib—Feeling abnormal—Acamprosate—alcohol dependence	0.000239	0.000971	CcSEcCtD
Nilotinib—Decreased appetite—Naltrexone—alcohol dependence	0.000239	0.00097	CcSEcCtD
Nilotinib—KIT—nervous system—alcohol dependence	0.000238	0.00148	CbGeAlD
Nilotinib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000237	0.000964	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000237	0.000963	CcSEcCtD
Nilotinib—PDGFRB—testis—alcohol dependence	0.000237	0.00147	CbGeAlD
Nilotinib—Fatigue—Naltrexone—alcohol dependence	0.000237	0.000962	CcSEcCtD
Nilotinib—Visual impairment—Citalopram—alcohol dependence	0.000236	0.000959	CcSEcCtD
Nilotinib—Constipation—Naltrexone—alcohol dependence	0.000235	0.000954	CcSEcCtD
Nilotinib—Pain—Naltrexone—alcohol dependence	0.000235	0.000954	CcSEcCtD
Nilotinib—CA1—endocrine gland—alcohol dependence	0.000232	0.00144	CbGeAlD
Nilotinib—PDGFRB—nervous system—alcohol dependence	0.000232	0.00144	CbGeAlD
Nilotinib—Erythema multiforme—Citalopram—alcohol dependence	0.000232	0.000941	CcSEcCtD
Nilotinib—Urticaria—Acamprosate—alcohol dependence	0.000231	0.000937	CcSEcCtD
Nilotinib—Body temperature increased—Acamprosate—alcohol dependence	0.000229	0.000932	CcSEcCtD
Nilotinib—Abdominal pain—Acamprosate—alcohol dependence	0.000229	0.000932	CcSEcCtD
Nilotinib—KIT—liver—alcohol dependence	0.000229	0.00142	CbGeAlD
Nilotinib—KIT—central nervous system—alcohol dependence	0.000229	0.00142	CbGeAlD
Nilotinib—Eye disorder—Citalopram—alcohol dependence	0.000229	0.00093	CcSEcCtD
Nilotinib—Tinnitus—Citalopram—alcohol dependence	0.000228	0.000927	CcSEcCtD
Nilotinib—PDGFRA—brain—alcohol dependence	0.000227	0.00141	CbGeAlD
Nilotinib—Cardiac disorder—Citalopram—alcohol dependence	0.000227	0.000923	CcSEcCtD
Nilotinib—Flushing—Citalopram—alcohol dependence	0.000227	0.000923	CcSEcCtD
Nilotinib—Feeling abnormal—Naltrexone—alcohol dependence	0.000226	0.000919	CcSEcCtD
Nilotinib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000225	0.000912	CcSEcCtD
Nilotinib—KIT—cerebellum—alcohol dependence	0.000224	0.00139	CbGeAlD
Nilotinib—PDGFRB—liver—alcohol dependence	0.000224	0.00139	CbGeAlD
Nilotinib—PDGFRB—central nervous system—alcohol dependence	0.000224	0.00139	CbGeAlD
Nilotinib—ABCG2—adrenal cortex—alcohol dependence	0.000223	0.00138	CbGeAlD
Nilotinib—Angiopathy—Citalopram—alcohol dependence	0.000222	0.000902	CcSEcCtD
Nilotinib—ABL1—endocrine gland—alcohol dependence	0.000221	0.00137	CbGeAlD
Nilotinib—Immune system disorder—Citalopram—alcohol dependence	0.000221	0.000898	CcSEcCtD
Nilotinib—Mediastinal disorder—Citalopram—alcohol dependence	0.000221	0.000896	CcSEcCtD
Nilotinib—CA4—digestive system—alcohol dependence	0.00022	0.00137	CbGeAlD
Nilotinib—Chills—Citalopram—alcohol dependence	0.00022	0.000893	CcSEcCtD
Nilotinib—CA2—cardiovascular system—alcohol dependence	0.00022	0.00136	CbGeAlD
Nilotinib—Arrhythmia—Citalopram—alcohol dependence	0.000219	0.000889	CcSEcCtD
Nilotinib—PDGFRB—cerebellum—alcohol dependence	0.000219	0.00136	CbGeAlD
Nilotinib—Urticaria—Naltrexone—alcohol dependence	0.000218	0.000886	CcSEcCtD
Nilotinib—CA1—nervous system—alcohol dependence	0.000218	0.00135	CbGeAlD
Nilotinib—Body temperature increased—Naltrexone—alcohol dependence	0.000217	0.000882	CcSEcCtD
Nilotinib—Abdominal pain—Naltrexone—alcohol dependence	0.000217	0.000882	CcSEcCtD
Nilotinib—Alopecia—Citalopram—alcohol dependence	0.000216	0.000879	CcSEcCtD
Nilotinib—Mental disorder—Citalopram—alcohol dependence	0.000215	0.000871	CcSEcCtD
Nilotinib—Hypersensitivity—Acamprosate—alcohol dependence	0.000214	0.000869	CcSEcCtD
Nilotinib—CA2—pancreas—alcohol dependence	0.000214	0.00133	CbGeAlD
Nilotinib—Erythema—Citalopram—alcohol dependence	0.000213	0.000866	CcSEcCtD
Nilotinib—Malnutrition—Citalopram—alcohol dependence	0.000213	0.000866	CcSEcCtD
Nilotinib—ABL1—testis—alcohol dependence	0.000211	0.00131	CbGeAlD
Nilotinib—Flatulence—Citalopram—alcohol dependence	0.00021	0.000853	CcSEcCtD
Nilotinib—CA12—brain—alcohol dependence	0.00021	0.0013	CbGeAlD
Nilotinib—CA1—liver—alcohol dependence	0.00021	0.0013	CbGeAlD
Nilotinib—CA4—blood—alcohol dependence	0.00021	0.0013	CbGeAlD
Nilotinib—CA1—central nervous system—alcohol dependence	0.00021	0.0013	CbGeAlD
Nilotinib—Dysgeusia—Citalopram—alcohol dependence	0.000209	0.000848	CcSEcCtD
Nilotinib—Asthenia—Acamprosate—alcohol dependence	0.000208	0.000846	CcSEcCtD
Nilotinib—ABL1—nervous system—alcohol dependence	0.000207	0.00129	CbGeAlD
Nilotinib—CA4—midbrain—alcohol dependence	0.000207	0.00128	CbGeAlD
Nilotinib—Back pain—Citalopram—alcohol dependence	0.000206	0.000838	CcSEcCtD
Nilotinib—CYP2B6—adrenal cortex—alcohol dependence	0.000206	0.00128	CbGeAlD
Nilotinib—Pruritus—Acamprosate—alcohol dependence	0.000205	0.000834	CcSEcCtD
Nilotinib—MAP2K5—brain—alcohol dependence	0.000205	0.00127	CbGeAlD
Nilotinib—Muscle spasms—Citalopram—alcohol dependence	0.000205	0.000833	CcSEcCtD
Nilotinib—Hypersensitivity—Naltrexone—alcohol dependence	0.000202	0.000822	CcSEcCtD
Nilotinib—Vision blurred—Citalopram—alcohol dependence	0.000201	0.000816	CcSEcCtD
Nilotinib—CSF1R—brain—alcohol dependence	0.0002	0.00124	CbGeAlD
Nilotinib—Tremor—Citalopram—alcohol dependence	0.0002	0.000811	CcSEcCtD
Nilotinib—ABL1—liver—alcohol dependence	0.0002	0.00124	CbGeAlD
Nilotinib—ABL1—central nervous system—alcohol dependence	0.000199	0.00124	CbGeAlD
Nilotinib—Diarrhoea—Acamprosate—alcohol dependence	0.000199	0.000807	CcSEcCtD
Nilotinib—Ill-defined disorder—Citalopram—alcohol dependence	0.000198	0.000803	CcSEcCtD
Nilotinib—Anaemia—Citalopram—alcohol dependence	0.000197	0.0008	CcSEcCtD
Nilotinib—Asthenia—Naltrexone—alcohol dependence	0.000197	0.0008	CcSEcCtD
Nilotinib—ABL1—cerebellum—alcohol dependence	0.000195	0.00121	CbGeAlD
Nilotinib—Pruritus—Naltrexone—alcohol dependence	0.000194	0.000789	CcSEcCtD
Nilotinib—Malaise—Citalopram—alcohol dependence	0.000192	0.000781	CcSEcCtD
Nilotinib—Dizziness—Acamprosate—alcohol dependence	0.000192	0.00078	CcSEcCtD
Nilotinib—Vertigo—Citalopram—alcohol dependence	0.000192	0.000778	CcSEcCtD
Nilotinib—Syncope—Citalopram—alcohol dependence	0.000191	0.000777	CcSEcCtD
Nilotinib—Leukopenia—Citalopram—alcohol dependence	0.000191	0.000775	CcSEcCtD
Nilotinib—Palpitations—Citalopram—alcohol dependence	0.000188	0.000765	CcSEcCtD
Nilotinib—Diarrhoea—Naltrexone—alcohol dependence	0.000188	0.000763	CcSEcCtD
Nilotinib—CYP2B6—cardiovascular system—alcohol dependence	0.000188	0.00117	CbGeAlD
Nilotinib—Loss of consciousness—Citalopram—alcohol dependence	0.000187	0.000761	CcSEcCtD
Nilotinib—Cough—Citalopram—alcohol dependence	0.000186	0.000756	CcSEcCtD
Nilotinib—CYP2C9—cardiovascular system—alcohol dependence	0.000186	0.00115	CbGeAlD
Nilotinib—Vomiting—Acamprosate—alcohol dependence	0.000185	0.00075	CcSEcCtD
Nilotinib—Hypertension—Citalopram—alcohol dependence	0.000184	0.000748	CcSEcCtD
Nilotinib—Rash—Acamprosate—alcohol dependence	0.000183	0.000743	CcSEcCtD
Nilotinib—Dermatitis—Acamprosate—alcohol dependence	0.000183	0.000743	CcSEcCtD
Nilotinib—CA2—digestive system—alcohol dependence	0.000182	0.00113	CbGeAlD
Nilotinib—KIT—brain—alcohol dependence	0.000182	0.00113	CbGeAlD
Nilotinib—Headache—Acamprosate—alcohol dependence	0.000182	0.000739	CcSEcCtD
Nilotinib—CA4—endocrine gland—alcohol dependence	0.000182	0.00113	CbGeAlD
Nilotinib—Dizziness—Naltrexone—alcohol dependence	0.000182	0.000738	CcSEcCtD
Nilotinib—Myalgia—Citalopram—alcohol dependence	0.000181	0.000737	CcSEcCtD
Nilotinib—Arthralgia—Citalopram—alcohol dependence	0.000181	0.000737	CcSEcCtD
Nilotinib—Chest pain—Citalopram—alcohol dependence	0.000181	0.000737	CcSEcCtD
Nilotinib—Anxiety—Citalopram—alcohol dependence	0.000181	0.000735	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00018	0.000732	CcSEcCtD
Nilotinib—Discomfort—Citalopram—alcohol dependence	0.000179	0.000728	CcSEcCtD
Nilotinib—PDGFRB—brain—alcohol dependence	0.000178	0.0011	CbGeAlD
Nilotinib—Dry mouth—Citalopram—alcohol dependence	0.000177	0.000721	CcSEcCtD
Nilotinib—Confusional state—Citalopram—alcohol dependence	0.000175	0.000713	CcSEcCtD
Nilotinib—Vomiting—Naltrexone—alcohol dependence	0.000175	0.000709	CcSEcCtD
Nilotinib—Oedema—Citalopram—alcohol dependence	0.000174	0.000707	CcSEcCtD
Nilotinib—CA2—blood—alcohol dependence	0.000174	0.00108	CbGeAlD
Nilotinib—CA4—testis—alcohol dependence	0.000173	0.00108	CbGeAlD
Nilotinib—Rash—Naltrexone—alcohol dependence	0.000173	0.000703	CcSEcCtD
Nilotinib—Dermatitis—Naltrexone—alcohol dependence	0.000173	0.000703	CcSEcCtD
Nilotinib—Infection—Citalopram—alcohol dependence	0.000173	0.000702	CcSEcCtD
Nilotinib—Nausea—Acamprosate—alcohol dependence	0.000172	0.0007	CcSEcCtD
Nilotinib—Headache—Naltrexone—alcohol dependence	0.000172	0.000699	CcSEcCtD
Nilotinib—CA2—midbrain—alcohol dependence	0.000172	0.00107	CbGeAlD
Nilotinib—Shock—Citalopram—alcohol dependence	0.000171	0.000695	CcSEcCtD
Nilotinib—CYP2D6—brainstem—alcohol dependence	0.000171	0.00106	CbGeAlD
Nilotinib—Nervous system disorder—Citalopram—alcohol dependence	0.000171	0.000693	CcSEcCtD
Nilotinib—CYP2B6—gonad—alcohol dependence	0.00017	0.00106	CbGeAlD
Nilotinib—Thrombocytopenia—Citalopram—alcohol dependence	0.00017	0.000692	CcSEcCtD
Nilotinib—CA4—nervous system—alcohol dependence	0.00017	0.00106	CbGeAlD
Nilotinib—Tachycardia—Citalopram—alcohol dependence	0.00017	0.00069	CcSEcCtD
Nilotinib—Skin disorder—Citalopram—alcohol dependence	0.000169	0.000686	CcSEcCtD
Nilotinib—Hyperhidrosis—Citalopram—alcohol dependence	0.000168	0.000683	CcSEcCtD
Nilotinib—CA1—brain—alcohol dependence	0.000166	0.00103	CbGeAlD
Nilotinib—Anorexia—Citalopram—alcohol dependence	0.000166	0.000674	CcSEcCtD
Nilotinib—CYP2C8—blood—alcohol dependence	0.000165	0.00103	CbGeAlD
Nilotinib—CYP2D6—forebrain—alcohol dependence	0.000165	0.00102	CbGeAlD
Nilotinib—CA4—central nervous system—alcohol dependence	0.000164	0.00102	CbGeAlD
Nilotinib—Nausea—Naltrexone—alcohol dependence	0.000163	0.000663	CcSEcCtD
Nilotinib—Hypotension—Citalopram—alcohol dependence	0.000163	0.00066	CcSEcCtD
Nilotinib—ABCG2—blood—alcohol dependence	0.000161	0.000999	CbGeAlD
Nilotinib—CA4—cerebellum—alcohol dependence	0.00016	0.000994	CbGeAlD
Nilotinib—ABCG2—midbrain—alcohol dependence	0.000159	0.000987	CbGeAlD
Nilotinib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000158	0.000644	CcSEcCtD
Nilotinib—ABL1—brain—alcohol dependence	0.000158	0.000983	CbGeAlD
Nilotinib—Insomnia—Citalopram—alcohol dependence	0.000157	0.000639	CcSEcCtD
Nilotinib—Paraesthesia—Citalopram—alcohol dependence	0.000156	0.000635	CcSEcCtD
Nilotinib—CYP2B6—digestive system—alcohol dependence	0.000156	0.000968	CbGeAlD
Nilotinib—Dyspnoea—Citalopram—alcohol dependence	0.000155	0.00063	CcSEcCtD
Nilotinib—CYP2C9—digestive system—alcohol dependence	0.000154	0.000958	CbGeAlD
Nilotinib—Dyspepsia—Citalopram—alcohol dependence	0.000153	0.000622	CcSEcCtD
Nilotinib—Decreased appetite—Citalopram—alcohol dependence	0.000151	0.000614	CcSEcCtD
Nilotinib—CA2—endocrine gland—alcohol dependence	0.000151	0.000936	CbGeAlD
Nilotinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00015	0.00061	CcSEcCtD
Nilotinib—Fatigue—Citalopram—alcohol dependence	0.00015	0.000609	CcSEcCtD
Nilotinib—Constipation—Citalopram—alcohol dependence	0.000149	0.000604	CcSEcCtD
Nilotinib—Pain—Citalopram—alcohol dependence	0.000149	0.000604	CcSEcCtD
Nilotinib—CYP2B6—blood—alcohol dependence	0.000148	0.000922	CbGeAlD
Nilotinib—CYP2C9—blood—alcohol dependence	0.000147	0.000913	CbGeAlD
Nilotinib—CA2—testis—alcohol dependence	0.000144	0.000892	CbGeAlD
Nilotinib—CYP2C8—endocrine gland—alcohol dependence	0.000144	0.000891	CbGeAlD
Nilotinib—Feeling abnormal—Citalopram—alcohol dependence	0.000143	0.000582	CcSEcCtD
Nilotinib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000142	0.000578	CcSEcCtD
Nilotinib—CA2—nervous system—alcohol dependence	0.000141	0.000876	CbGeAlD
Nilotinib—Urticaria—Citalopram—alcohol dependence	0.000138	0.000561	CcSEcCtD
Nilotinib—Abdominal pain—Citalopram—alcohol dependence	0.000138	0.000559	CcSEcCtD
Nilotinib—Body temperature increased—Citalopram—alcohol dependence	0.000138	0.000559	CcSEcCtD
Nilotinib—CYP2C8—testis—alcohol dependence	0.000137	0.00085	CbGeAlD
Nilotinib—CA2—liver—alcohol dependence	0.000136	0.000844	CbGeAlD
Nilotinib—CA2—central nervous system—alcohol dependence	0.000136	0.000843	CbGeAlD
Nilotinib—ABCG2—testis—alcohol dependence	0.000133	0.000826	CbGeAlD
Nilotinib—CA2—cerebellum—alcohol dependence	0.000133	0.000824	CbGeAlD
Nilotinib—CA4—brain—alcohol dependence	0.00013	0.000807	CbGeAlD
Nilotinib—CYP2C8—liver—alcohol dependence	0.000129	0.000804	CbGeAlD
Nilotinib—CYP2B6—endocrine gland—alcohol dependence	0.000129	0.0008	CbGeAlD
Nilotinib—Hypersensitivity—Citalopram—alcohol dependence	0.000128	0.000521	CcSEcCtD
Nilotinib—CYP2C9—endocrine gland—alcohol dependence	0.000127	0.000792	CbGeAlD
Nilotinib—ABCG2—liver—alcohol dependence	0.000126	0.000781	CbGeAlD
Nilotinib—Asthenia—Citalopram—alcohol dependence	0.000125	0.000507	CcSEcCtD
Nilotinib—Pruritus—Citalopram—alcohol dependence	0.000123	0.0005	CcSEcCtD
Nilotinib—ABCG2—cerebellum—alcohol dependence	0.000123	0.000763	CbGeAlD
Nilotinib—CYP2B6—testis—alcohol dependence	0.000123	0.000762	CbGeAlD
Nilotinib—CYP2B6—nervous system—alcohol dependence	0.00012	0.000748	CbGeAlD
Nilotinib—Diarrhoea—Citalopram—alcohol dependence	0.000119	0.000484	CcSEcCtD
Nilotinib—ABCB1—forebrain—alcohol dependence	0.000119	0.000737	CbGeAlD
Nilotinib—CYP3A4—digestive system—alcohol dependence	0.000118	0.000731	CbGeAlD
Nilotinib—CYP2B6—liver—alcohol dependence	0.000116	0.000721	CbGeAlD
Nilotinib—CYP2B6—central nervous system—alcohol dependence	0.000116	0.00072	CbGeAlD
Nilotinib—CYP2D6—digestive system—alcohol dependence	0.000116	0.000719	CbGeAlD
Nilotinib—Dizziness—Citalopram—alcohol dependence	0.000115	0.000467	CcSEcCtD
Nilotinib—CYP2C9—liver—alcohol dependence	0.000115	0.000714	CbGeAlD
Nilotinib—CYP3A4—blood—alcohol dependence	0.000112	0.000696	CbGeAlD
Nilotinib—Vomiting—Citalopram—alcohol dependence	0.000111	0.000449	CcSEcCtD
Nilotinib—CYP2D6—blood—alcohol dependence	0.00011	0.000685	CbGeAlD
Nilotinib—ABCB1—adrenal cortex—alcohol dependence	0.00011	0.000683	CbGeAlD
Nilotinib—Rash—Citalopram—alcohol dependence	0.00011	0.000446	CcSEcCtD
Nilotinib—Dermatitis—Citalopram—alcohol dependence	0.00011	0.000445	CcSEcCtD
Nilotinib—Headache—Citalopram—alcohol dependence	0.000109	0.000443	CcSEcCtD
Nilotinib—CA2—brain—alcohol dependence	0.000108	0.000669	CbGeAlD
Nilotinib—Nausea—Citalopram—alcohol dependence	0.000103	0.00042	CcSEcCtD
Nilotinib—CYP2C8—brain—alcohol dependence	0.000103	0.000638	CbGeAlD
Nilotinib—ABCB1—cardiovascular system—alcohol dependence	0.0001	0.000623	CbGeAlD
Nilotinib—ABCG2—brain—alcohol dependence	9.98e-05	0.00062	CbGeAlD
Nilotinib—ABCB1—pancreas—alcohol dependence	9.75e-05	0.000606	CbGeAlD
Nilotinib—CYP3A4—endocrine gland—alcohol dependence	9.72e-05	0.000604	CbGeAlD
Nilotinib—CYP2D6—endocrine gland—alcohol dependence	9.57e-05	0.000594	CbGeAlD
Nilotinib—CYP2B6—brain—alcohol dependence	9.21e-05	0.000572	CbGeAlD
Nilotinib—CYP2D6—testis—alcohol dependence	9.12e-05	0.000567	CbGeAlD
Nilotinib—ABCB1—gonad—alcohol dependence	9.1e-05	0.000565	CbGeAlD
Nilotinib—CYP3A4—nervous system—alcohol dependence	9.1e-05	0.000565	CbGeAlD
Nilotinib—CYP2D6—nervous system—alcohol dependence	8.95e-05	0.000556	CbGeAlD
Nilotinib—CYP3A4—liver—alcohol dependence	8.76e-05	0.000544	CbGeAlD
Nilotinib—CYP3A4—central nervous system—alcohol dependence	8.76e-05	0.000544	CbGeAlD
Nilotinib—CYP2D6—liver—alcohol dependence	8.62e-05	0.000536	CbGeAlD
Nilotinib—CYP2D6—central nervous system—alcohol dependence	8.62e-05	0.000535	CbGeAlD
Nilotinib—CYP2D6—cerebellum—alcohol dependence	8.43e-05	0.000523	CbGeAlD
Nilotinib—ABCB1—digestive system—alcohol dependence	8.33e-05	0.000517	CbGeAlD
Nilotinib—ABCB1—blood—alcohol dependence	7.93e-05	0.000493	CbGeAlD
Nilotinib—ABCB1—midbrain—alcohol dependence	7.83e-05	0.000487	CbGeAlD
Nilotinib—ABCB1—endocrine gland—alcohol dependence	6.88e-05	0.000427	CbGeAlD
Nilotinib—CYP2D6—brain—alcohol dependence	6.84e-05	0.000425	CbGeAlD
Nilotinib—ABCB1—testis—alcohol dependence	6.56e-05	0.000408	CbGeAlD
Nilotinib—ABCB1—nervous system—alcohol dependence	6.44e-05	0.0004	CbGeAlD
Nilotinib—ABCB1—liver—alcohol dependence	6.2e-05	0.000385	CbGeAlD
Nilotinib—ABCB1—central nervous system—alcohol dependence	6.2e-05	0.000385	CbGeAlD
Nilotinib—ABCB1—cerebellum—alcohol dependence	6.06e-05	0.000376	CbGeAlD
Nilotinib—ABCB1—brain—alcohol dependence	4.92e-05	0.000306	CbGeAlD
Nilotinib—MAPK14—Signaling Pathways—WASF1—alcohol dependence	2.16e-05	0.000172	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NPY—alcohol dependence	2.14e-05	0.00017	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CHRM2—alcohol dependence	2.12e-05	0.000169	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—DRD4—alcohol dependence	2.12e-05	0.000168	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ADH1A—alcohol dependence	2.1e-05	0.000167	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PDYN—alcohol dependence	2.1e-05	0.000167	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—OPRM1—alcohol dependence	2.1e-05	0.000167	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—DRD4—alcohol dependence	2.1e-05	0.000167	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GGT2—alcohol dependence	2.1e-05	0.000167	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—AVP—alcohol dependence	2.08e-05	0.000166	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ADH1A—alcohol dependence	2.08e-05	0.000166	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—GOT1—alcohol dependence	2.08e-05	0.000165	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR1B—alcohol dependence	2.07e-05	0.000164	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CRH—alcohol dependence	2.07e-05	0.000164	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—OPRM1—alcohol dependence	2.05e-05	0.000163	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CNR1—alcohol dependence	2.02e-05	0.000161	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CNR1—alcohol dependence	2e-05	0.000159	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—AVP—alcohol dependence	1.98e-05	0.000158	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR7—alcohol dependence	1.97e-05	0.000157	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—DRD2—alcohol dependence	1.97e-05	0.000157	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—DRD2—alcohol dependence	1.95e-05	0.000155	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR7—alcohol dependence	1.95e-05	0.000155	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—WASF2—alcohol dependence	1.95e-05	0.000155	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CRHR1—alcohol dependence	1.95e-05	0.000155	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—OPRM1—alcohol dependence	1.95e-05	0.000155	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—EP300—alcohol dependence	1.94e-05	0.000155	CbGpPWpGaD
Nilotinib—CA4—Metabolism—POMC—alcohol dependence	1.93e-05	0.000154	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NPY—alcohol dependence	1.93e-05	0.000154	CbGpPWpGaD
Nilotinib—LCK—Disease—GOT2—alcohol dependence	1.93e-05	0.000153	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ADH1B—alcohol dependence	1.92e-05	0.000152	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—DRD4—alcohol dependence	1.91e-05	0.000152	CbGpPWpGaD
Nilotinib—CA14—Metabolism—EP300—alcohol dependence	1.91e-05	0.000152	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ADH4—alcohol dependence	1.9e-05	0.000151	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NPY—alcohol dependence	1.89e-05	0.00015	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.88e-05	0.00015	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—WASF1—alcohol dependence	1.87e-05	0.000149	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CRH—alcohol dependence	1.86e-05	0.000148	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR1B—alcohol dependence	1.86e-05	0.000148	CbGpPWpGaD
Nilotinib—CA6—Metabolism—EP300—alcohol dependence	1.86e-05	0.000148	CbGpPWpGaD
Nilotinib—CA2—Metabolism—POMC—alcohol dependence	1.85e-05	0.000147	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ADH7—alcohol dependence	1.85e-05	0.000147	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GOT2—alcohol dependence	1.85e-05	0.000147	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—ALDH2—alcohol dependence	1.84e-05	0.000146	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CHRM2—alcohol dependence	1.83e-05	0.000146	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CRH—alcohol dependence	1.82e-05	0.000145	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR1B—alcohol dependence	1.82e-05	0.000145	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CNR1—alcohol dependence	1.82e-05	0.000145	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—DRD4—alcohol dependence	1.81e-05	0.000144	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NPY—alcohol dependence	1.79e-05	0.000142	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ADH4—alcohol dependence	1.79e-05	0.000142	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—DRD2—alcohol dependence	1.78e-05	0.000141	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR7—alcohol dependence	1.78e-05	0.000141	CbGpPWpGaD
Nilotinib—CA1—Metabolism—POMC—alcohol dependence	1.78e-05	0.000141	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GGT2—alcohol dependence	1.77e-05	0.000141	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ADH4—alcohol dependence	1.77e-05	0.000141	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—EP300—alcohol dependence	1.75e-05	0.000139	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CYP2E1—alcohol dependence	1.74e-05	0.000138	CbGpPWpGaD
Nilotinib—CA7—Metabolism—EP300—alcohol dependence	1.73e-05	0.000138	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HTR2A—alcohol dependence	1.73e-05	0.000138	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR1B—alcohol dependence	1.73e-05	0.000137	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CRH—alcohol dependence	1.73e-05	0.000137	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CNR1—alcohol dependence	1.73e-05	0.000137	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR7—alcohol dependence	1.68e-05	0.000134	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—DRD2—alcohol dependence	1.68e-05	0.000134	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—OPRM1—alcohol dependence	1.68e-05	0.000134	CbGpPWpGaD
Nilotinib—LCK—Disease—GOT1—alcohol dependence	1.67e-05	0.000132	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—AVP—alcohol dependence	1.66e-05	0.000132	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—EP300—alcohol dependence	1.66e-05	0.000132	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADH6—alcohol dependence	1.66e-05	0.000132	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—EP300—alcohol dependence	1.66e-05	0.000132	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	1.66e-05	0.000132	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—EP300—alcohol dependence	1.65e-05	0.000131	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HTR2A—alcohol dependence	1.65e-05	0.000131	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—AVP—alcohol dependence	1.64e-05	0.000131	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—DRD4—alcohol dependence	1.63e-05	0.000129	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—EP300—alcohol dependence	1.63e-05	0.000129	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ADH1B—alcohol dependence	1.62e-05	0.000129	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—EP300—alcohol dependence	1.62e-05	0.000129	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ADH7—alcohol dependence	1.61e-05	0.000128	CbGpPWpGaD
Nilotinib—CA12—Metabolism—EP300—alcohol dependence	1.61e-05	0.000128	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—DRD4—alcohol dependence	1.59e-05	0.000127	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GGT1—alcohol dependence	1.59e-05	0.000127	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GOT1—alcohol dependence	1.59e-05	0.000127	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MAOB—alcohol dependence	1.59e-05	0.000126	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—EP300—alcohol dependence	1.57e-05	0.000125	CbGpPWpGaD
Nilotinib—HCK—Immune System—EP300—alcohol dependence	1.57e-05	0.000125	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GOT2—alcohol dependence	1.57e-05	0.000125	CbGpPWpGaD
Nilotinib—CA9—Metabolism—POMC—alcohol dependence	1.56e-05	0.000124	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CNR1—alcohol dependence	1.55e-05	0.000124	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NPY—alcohol dependence	1.55e-05	0.000123	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GGT2—alcohol dependence	1.55e-05	0.000123	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—EP300—alcohol dependence	1.54e-05	0.000123	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	1.54e-05	0.000122	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.53e-05	0.000122	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CNR1—alcohol dependence	1.52e-05	0.000121	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	1.52e-05	0.000121	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ADH7—alcohol dependence	1.52e-05	0.000121	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—DRD2—alcohol dependence	1.52e-05	0.000121	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR7—alcohol dependence	1.52e-05	0.000121	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—DRD4—alcohol dependence	1.51e-05	0.00012	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ADH7—alcohol dependence	1.51e-05	0.00012	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—AVP—alcohol dependence	1.5e-05	0.000119	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR1B—alcohol dependence	1.49e-05	0.000119	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CRH—alcohol dependence	1.49e-05	0.000119	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—EP300—alcohol dependence	1.49e-05	0.000119	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR7—alcohol dependence	1.48e-05	0.000118	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—DRD2—alcohol dependence	1.48e-05	0.000118	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CYP2E1—alcohol dependence	1.47e-05	0.000117	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—EP300—alcohol dependence	1.46e-05	0.000116	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—EP300—alcohol dependence	1.46e-05	0.000116	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GGT2—alcohol dependence	1.46e-05	0.000116	CbGpPWpGaD
Nilotinib—HCK—Disease—EP300—alcohol dependence	1.45e-05	0.000115	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GGT2—alcohol dependence	1.44e-05	0.000115	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CNR1—alcohol dependence	1.44e-05	0.000115	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—MAOA—alcohol dependence	1.43e-05	0.000114	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—EP300—alcohol dependence	1.42e-05	0.000113	CbGpPWpGaD
Nilotinib—BLK—Immune System—EP300—alcohol dependence	1.42e-05	0.000113	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—AVP—alcohol dependence	1.42e-05	0.000113	CbGpPWpGaD
Nilotinib—FGR—Immune System—EP300—alcohol dependence	1.42e-05	0.000113	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ADH1B—alcohol dependence	1.41e-05	0.000112	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—DRD2—alcohol dependence	1.41e-05	0.000112	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR7—alcohol dependence	1.41e-05	0.000112	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—EP300—alcohol dependence	1.39e-05	0.00011	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—POMC—alcohol dependence	1.38e-05	0.00011	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR2A—alcohol dependence	1.38e-05	0.00011	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.37e-05	0.000109	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.37e-05	0.000109	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR2A—alcohol dependence	1.37e-05	0.000109	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GGT1—alcohol dependence	1.35e-05	0.000107	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GOT1—alcohol dependence	1.35e-05	0.000107	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ALDH2—alcohol dependence	1.35e-05	0.000107	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MAOB—alcohol dependence	1.34e-05	0.000107	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—EP300—alcohol dependence	1.33e-05	0.000106	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ADH1B—alcohol dependence	1.33e-05	0.000106	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ADH1B—alcohol dependence	1.32e-05	0.000105	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—POMC—alcohol dependence	1.32e-05	0.000105	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—DRD4—alcohol dependence	1.31e-05	0.000104	CbGpPWpGaD
Nilotinib—CA4—Metabolism—EP300—alcohol dependence	1.28e-05	0.000102	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—AVP—alcohol dependence	1.28e-05	0.000102	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—AVP—alcohol dependence	1.25e-05	9.94e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CNR1—alcohol dependence	1.25e-05	9.92e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR2A—alcohol dependence	1.25e-05	9.9e-05	CbGpPWpGaD
Nilotinib—CA2—Metabolism—EP300—alcohol dependence	1.23e-05	9.77e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—DRD2—alcohol dependence	1.22e-05	9.68e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR7—alcohol dependence	1.22e-05	9.68e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—MAOA—alcohol dependence	1.21e-05	9.63e-05	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—EP300—alcohol dependence	1.2e-05	9.54e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—AVP—alcohol dependence	1.18e-05	9.42e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR2A—alcohol dependence	1.18e-05	9.38e-05	CbGpPWpGaD
Nilotinib—CA1—Metabolism—EP300—alcohol dependence	1.18e-05	9.36e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MAOB—alcohol dependence	1.17e-05	9.31e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADH4—alcohol dependence	1.17e-05	9.29e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GOT2—alcohol dependence	1.15e-05	9.13e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ALDH2—alcohol dependence	1.14e-05	9.09e-05	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—EP300—alcohol dependence	1.13e-05	9e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MAOB—alcohol dependence	1.1e-05	8.78e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—POMC—alcohol dependence	1.1e-05	8.77e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.1e-05	8.74e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MAOB—alcohol dependence	1.09e-05	8.7e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—POMC—alcohol dependence	1.09e-05	8.69e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CYP2E1—alcohol dependence	1.08e-05	8.58e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR2A—alcohol dependence	1.06e-05	8.45e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR2A—alcohol dependence	1.04e-05	8.27e-05	CbGpPWpGaD
Nilotinib—BRAF—Disease—EP300—alcohol dependence	1.04e-05	8.23e-05	CbGpPWpGaD
Nilotinib—CA9—Metabolism—EP300—alcohol dependence	1.04e-05	8.23e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—AVP—alcohol dependence	1.02e-05	8.15e-05	CbGpPWpGaD
Nilotinib—KIT—Immune System—EP300—alcohol dependence	1.02e-05	8.12e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ALDH2—alcohol dependence	9.96e-06	7.92e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—POMC—alcohol dependence	9.95e-06	7.91e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADH7—alcohol dependence	9.93e-06	7.9e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GGT1—alcohol dependence	9.91e-06	7.88e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GOT1—alcohol dependence	9.91e-06	7.88e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR2A—alcohol dependence	9.86e-06	7.84e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GOT2—alcohol dependence	9.72e-06	7.73e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—EP300—alcohol dependence	9.66e-06	7.68e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GGT2—alcohol dependence	9.52e-06	7.57e-05	CbGpPWpGaD
Nilotinib—KIT—Disease—EP300—alcohol dependence	9.42e-06	7.49e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—POMC—alcohol dependence	9.42e-06	7.49e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ALDH2—alcohol dependence	9.38e-06	7.46e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ALDH2—alcohol dependence	9.3e-06	7.4e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—POMC—alcohol dependence	9.3e-06	7.39e-05	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—EP300—alcohol dependence	9.19e-06	7.3e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CYP2E1—alcohol dependence	9.14e-06	7.27e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	8.94e-06	7.11e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—EP300—alcohol dependence	8.92e-06	7.09e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—MAOA—alcohol dependence	8.88e-06	7.06e-05	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—EP300—alcohol dependence	8.73e-06	6.94e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	8.71e-06	6.92e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—EP300—alcohol dependence	8.7e-06	6.92e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2A—alcohol dependence	8.52e-06	6.78e-05	CbGpPWpGaD
Nilotinib—LYN—Immune System—EP300—alcohol dependence	8.52e-06	6.78e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—POMC—alcohol dependence	8.48e-06	6.75e-05	CbGpPWpGaD
Nilotinib—ABL1—Immune System—EP300—alcohol dependence	8.48e-06	6.74e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GOT2—alcohol dependence	8.47e-06	6.73e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GOT1—alcohol dependence	8.39e-06	6.67e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GGT1—alcohol dependence	8.39e-06	6.67e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—POMC—alcohol dependence	8.31e-06	6.6e-05	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—EP300—alcohol dependence	8.08e-06	6.42e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—EP300—alcohol dependence	8.04e-06	6.39e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GOT2—alcohol dependence	7.98e-06	6.34e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	7.96e-06	6.33e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GOT2—alcohol dependence	7.91e-06	6.29e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—POMC—alcohol dependence	7.89e-06	6.27e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—POMC—alcohol dependence	7.87e-06	6.26e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—MAOA—alcohol dependence	7.52e-06	5.98e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP2E1—alcohol dependence	7.5e-06	5.97e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP2E1—alcohol dependence	7.44e-06	5.91e-05	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—EP300—alcohol dependence	7.32e-06	5.82e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GGT1—alcohol dependence	7.31e-06	5.81e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GOT1—alcohol dependence	7.31e-06	5.81e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	7.29e-06	5.8e-05	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—EP300—alcohol dependence	7.25e-06	5.76e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MAOB—alcohol dependence	7.22e-06	5.74e-05	CbGpPWpGaD
Nilotinib—LCK—Immune System—EP300—alcohol dependence	6.99e-06	5.55e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GOT1—alcohol dependence	6.89e-06	5.48e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GGT1—alcohol dependence	6.89e-06	5.48e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GGT1—alcohol dependence	6.83e-06	5.43e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GOT1—alcohol dependence	6.83e-06	5.43e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—POMC—alcohol dependence	6.81e-06	5.41e-05	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—EP300—alcohol dependence	6.6e-06	5.25e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MAOA—alcohol dependence	6.55e-06	5.21e-05	CbGpPWpGaD
Nilotinib—LCK—Disease—EP300—alcohol dependence	6.45e-06	5.13e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—EP300—alcohol dependence	6.25e-06	4.97e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MAOA—alcohol dependence	6.17e-06	4.91e-05	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—EP300—alcohol dependence	6.17e-06	4.9e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	6.14e-06	4.88e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MAOA—alcohol dependence	6.12e-06	4.87e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	5.93e-06	4.72e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—POMC—alcohol dependence	5.78e-06	4.6e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—EP300—alcohol dependence	5.63e-06	4.47e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—EP300—alcohol dependence	5.51e-06	4.38e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—EP300—alcohol dependence	5.23e-06	4.16e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—EP300—alcohol dependence	5.22e-06	4.15e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GOT2—alcohol dependence	5.22e-06	4.15e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	4.9e-06	3.9e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—POMC—alcohol dependence	4.89e-06	3.89e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—EP300—alcohol dependence	4.52e-06	3.59e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GGT1—alcohol dependence	4.5e-06	3.58e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GOT1—alcohol dependence	4.5e-06	3.58e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—POMC—alcohol dependence	4.26e-06	3.39e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MAOA—alcohol dependence	4.04e-06	3.21e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—POMC—alcohol dependence	4.02e-06	3.2e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—POMC—alcohol dependence	3.98e-06	3.17e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—EP300—alcohol dependence	3.84e-06	3.05e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—EP300—alcohol dependence	3.25e-06	2.58e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—EP300—alcohol dependence	2.83e-06	2.25e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—EP300—alcohol dependence	2.67e-06	2.12e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—EP300—alcohol dependence	2.64e-06	2.1e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—POMC—alcohol dependence	2.63e-06	2.09e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—EP300—alcohol dependence	1.74e-06	1.39e-05	CbGpPWpGaD
